Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis
Thrombosis and Haemostasis · 01.10.2025 · 125 (10) · 1010-1022
DOI: 10.1055/a-2498-4849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.10.2025. Verfasst von Blanca De Moner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona,…. Hauptthemen laut MEDLINE: Janus Kinase 2, Venous Thrombosis, Myeloproliferative Disorders, Endothelial Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
JAK2V617F-mutated myeloproliferative neoplasms (MPN) exhibit abnormal proliferation of bone marrow progenitors and increased risk of thrombosis, specifically in splanchnic veins (SVT). The contribution of the endothelium to the development of the prothrombotic phenotype was explored. Plasma and serum samples from JAK2V617F MPN patients with (n=26) or without (n=7) thrombotic debut and different treatments, were obtained (n=33). Cultured endothelial cells (ECs) were exposed to serum samples from these patients and from healthy donors as controls. Changes in markers of inflammation (VCAM-1, ICAM-1), cell permeability (VE-cadherin), production of VWF, extracellular matrix (ECM) reactivity, and activation of intracellular signaling pathways related to stress, proliferation, inflammation (Akt, p44/42, IkBa), and JAK2/STAT3 pathway, were assessed by immunofluorescence, flow adhesion, SDS-PAGE and immunoblot. Additionally, circulating markers of endothelial activation and damage (VWF, sVCAM-1, sTNFRI, thrombomodulin, angiopoietin-2, a2-antiplasmin activity, PAI-1) were evaluated in Patients' plasma. The in vitro studies showed that EC exposure to MPN thrombotic patients' sera resulted in increased VCAM-1 and ICAM-1, and reduced VE-cadherin expression (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), U…
- Josep Carreras Leukaemia Research Institute, University of Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain.
- Barcelona Endothelium Team, Barcelona, Spain.
- Hematopathology Section, Pathology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, IDIBAPS, Spain.
- Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
- Hemostasis and Hemotherapy Department, Institut del Càncer i Malalties de la Sang (ICAMS), Hospital Clínic de Barcelona, Barcelona, Spain.
ORCID-Profile: Blanca De Moner, Eduardo Arellano-Rodrigo
Zitieren
APA
De Moner, B., Martinez-Sanchez, J., Garrote, M., Ramos, A., Ventosa-Capell, H., Moreno-Castaño, A., Nomdedeu, M., Ojeda, A., Escolar, G., Garcia-Pagan, J. C., Arellano-Rodrigo, E., Carreras, E., Alvarez-Larran, A., & Díaz-Ricart, M. (2025). Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis. Thrombosis and Haemostasis, 125(10), 1010-1022. https://doi.org/10.1055/a-2498-4849
Vancouver
De Moner B, Martinez-Sanchez J, Garrote M, Ramos A, Ventosa-Capell H, Moreno-Castaño A, et al. Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis. Thrombosis and Haemostasis. 2025;125(10):1010-1022. doi:10.1055/a-2498-4849
BibTeX
@article{DeMoner2025,
author = {De Moner, Blanca and Martinez-Sanchez, Julia and Garrote, Marta and Ramos, Alex and Ventosa-Capell, Helena and Moreno-Castaño, Ana and Nomdedeu, Meritxell and Ojeda, Asunción and Escolar, Gines and Garcia-Pagan, Joan Carles and Arellano-Rodrigo, Eduardo and Carreras, Enric and Alvarez-Larran, Alberto and Díaz-Ricart, Maribel},
title = {Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {10},
pages = {1010--1022},
doi = {10.1055/a-2498-4849}
}
EUVIMED